Oropharyngeal Candidiasis

Respiratory arrest, Bronchospasm, Cyanosis, Oropharyngeal swelling, Cough, Sneezing

muscle cramp, myalgia

weight gain, polydipsia

Uncommon candidiasis, staphylococcal infection.

Anogenital candidiasis

Blood and lymphatic disorders

Very rare moniliasis (gastro intestinal), pancreatitis.

Rare pseudomembranous colitis, moniliasis (oral).

Throat separately (oropharyngeal deposition and hence swallowed dose), Pooling 1

Invasive Candidiasis in Adult Patients

Pancreatitis, candidiasis of oesophagus and glossitis.

Candidaemia and other forms of Invasive Candidiasis

Invasive candidiasis is a life threatening disease..

Of these, 37 had invasive candidiasis, 10 had invasive aspergillosis, and 1 patient had esophageal candidiasis.

81 (30 37) in invasive candidiasis, 50 (5 10) in invasive aspergillosis, and 100 (1 1) in esophageal candidiasis.

Infection Pustules Herpes simplex Genital candidiasis Vaginitis Bacterial infection Fungal infection Upper respiratory tract infection Vulvitis Rhinitis Influenza Blood and lymphatic system disorders

Infections Common influenza like symptoms, respiratory tract infection (e. g bronchitis), urinary tract infection Uncommon candidiasis, ear infection, herpes simplex, tooth infection

Hypersensitivity reactions with the following manifestations

Infections Candidiasis of the mouth Infestations

Candidiasis of the mouth and throat

104 febrile, neutropenic patients 56 patients with invasive candidiasis 1 patient with esophageal candidiasis and 10 patients with invasive aspergillosis.

In oropharyngeal candidiasis, Noxafil was as effective as fluconazole.

lower respiratory infections (including pneumonia, bronchitis), viral infections (including influenza, herpes infections),

Infection, urinary tract infection, folliculitis, upper respiratory tract infection, candidiasis, sinusitis

Treatment of invasive candidiasis in adult non neutropenic patients.

In oropharyngeal candidiasis, Posaconazole SP was as effective as fluconazole.

Rare acute renal failure, impaired renal function, vaginal moniliasis, haematuria, crystalluria, interstitial nephritis.

Rare uveitis, scleritis, episcleritis Common abdominal pain, dyspepsia, constipation, diarrhoea, flatulence, oesophageal ulcer , dysphagia , abdominal distension, acid regurgitation Uncommon nausea, vomiting, gastritis, oesophagitis , oesophageal erosions , melena Rare oesophageal stricture , oropharyngeal ulceration , upper gastrointestinal PUBs (perforation, ulcers, bleeding)(see section 4.4). See sections 4.2 and 4.4

ECALTA has been studied in one main study involving 261 patients with invasive candidiasis.

Septic shock , sepsis, bacteraemia, pneumonia, herpes zoster, herpes simplex, implant infection, oral candidiasis

if you have a history of predisposition to candidiasis overgrowth or are currently

CANCIDAS may have been prescribed to treat a serious fungal infection called invasive candidiasis.

ECALTA was more effective than fluconazole in treating invasive candidiasis.

The dose can then be inhaled and the device closed.

Concomitant use of other beta adrenergic containing drugs can have a potentially additive effect.

672 in Phase 2 3 trials (287 patients with candidaemia invasive candidiasis, 355 patients with oral oesophageal candidiasis, 30 patients with invasive aspergillosis), and 257 in Phase I studies.

Sepsis, Urinary tract infection, Cellulitis, Tonsillitis, Pharyngitis, Oral candidiasis, Influenza, Gastroenteritis, Fungal infection, Infection, Tooth abscess

30 to 49 for AUC).

In controlled and open label studies with Humira, serious infections (including fatal infections, which occurred rarely) have been reported, which include reports of tuberculosis (including miliary and extra pulmonary locations) and invasive opportunistic infections (e. g. disseminated or extrapulmonary histoplasmosis, blastomycosis, coccidioidomycosis, pneumocystis, candidiasis, aspergillosis and listeriosis).

In controlled and open label studies with Humira, serious infections (including fatal infections, which occurred rarely) have been reported, which include reports of tuberculosis (including miliary and extra pulmonary locations) and invasive opportunistic infections (e. g. disseminated or extrapulmonary histoplasmosis, blastomycosis, coccidioidomycosis, pneumocystis candidiasis, aspergillosis and listeriosis).

In controlled and open label studies with Humira, serious infections (including fatal infections, which occurred rarely) have been reported, which include reports of tuberculosis (including miliary and extra pulmonary locations) and invasive opportunistic infections (e. g. disseminated or extrapulmonary histoplasmosis,, blastomycosis, coccidioidomycosis, pneumocystis, candidiasis, aspergillosis and listeriosis).

The management of asthma should normally follow a stepwise programme and patient response should be monitored clinically and by lung function tests.

Both hoarseness and incidence of candidiasis may be relieved by gargling with water after using the product.

Three studies looked at the effects of Cancidas in the treatment of invasive candidiasis or aspergillosis one study involved 239 adults with invasive candidiasis, another involved 69 adults with invasive aspergillosis, and the third involved 49 patients aged between six months and 17 years with either candidiasis or aspergillosis.